Citation Impact
Citing Papers
Guidelines for Management of Ischaemic Stroke and Transient Ischaemic Attack 2008
2008 Standout
Fourteen-year final report of the randomized PDRG-UK trial comparing three initial treatments in PD
2008
Guidelines for the Early Management of Adults With Ischemic Stroke
2007
Stroke rehabilitation
2011 Standout
Adalimumab, etanercept and ustekinumab for treating plaque psoriasis in children and young people: systematic review and economic evaluation
2017
Child abuse: Adolescent records vs. adult recall
1990 Standout
2010 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada: summary
2010
A Clinical Trial of Vena Caval Filters in the Prevention of Pulmonary Embolism in Patients with Proximal Deep-Vein Thrombosis
1998 Standout
The Hypothalamic–Pituitary–Adrenal Axis and Immune-Mediated Inflammation
1995 Standout
Low Molecular Weight Heparin
1997
Intracerebral haemorrhage
2009 Standout
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
Glucocorticoid-Induced Osteoporosis: Pathogenesis and Management
1990
Roles of individual prolyl‐4‐hydroxylase isoforms in the first 24 hours following transient focal cerebral ischaemia: insights from genetically modified mice
2012 StandoutNobel
Prevention of Corticosteroid Osteoporosis -- A Comparison of Calcium, Calcitriol, and Calcitonin
1993
Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial
1998 Standout
Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
2003 Standout
Prevention of venous thromboembolism after acute ischemic stroke
2005
Randomized controlled study of heparin and low molecular weight heparin for prevention of deep-vein thrombosis in medical patients
1990
Vitamin D Deficiency
2007 Standout
Subcutaneous Low-Molecular-Weight Heparin Compared with Continuous Intravenous Heparin in the Treatment of Proximal-Vein Thrombosis
1992 Standout
Aspirin plus Clopidogrel as Secondary Prevention after Stroke or Transient Ischemic Attack: A Systematic Review and Meta-Analysis
2014 Standout
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009 Standout
Impracticability of Informed Consent in the Registry of the Canadian Stroke Network
2004 Standout
Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study
2007 Standout
Osteoporosis: now and the future
2011 Standout
Prevention of fatal pulmonary embolism and mortality in surgical patients
2005
Parkinson's disease
2009 Standout
Assessing the quality of reports of randomized clinical trials: Is blinding necessary?
1996 Standout
Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study
2008 Standout
Antithrombotic and Thrombolytic Therapy for Ischemic Stroke
2008
Antithrombotic and Thrombolytic Therapy for Ischemic Stroke
2004
Incidental Findings on Brain MRI in the General Population
2007 Standout
Dabigatran versus Warfarin in the Treatment of Acute Venous Thromboembolism
2009 Standout
Does Lowering the Blood Pressure Improve the Mood? Quality-of-Life Results from the Hypertension Optimal Treatment (HOT) Study
1997
Platelet Activation and Atherothrombosis
2007 Standout
Low molecular weight versus standard heparin for prevention of venous thromboembolism after major abdominal surgery
1993
Low molecular weight heparin versus aspirin for acute ischemic stroke: A systematic review
2002
Alginate: Properties and biomedical applications
2011 Standout
Users' Guides to the Medical Literature
2000 Standout
A Five-Year Study of the Incidence of Dyskinesia in Patients with Early Parkinson's Disease Who Were Treated with Ropinirole or Levodopa
2000 Standout
Thromboprophylaxis and death after total hip replacement
1996
The Clinical Course of Pulmonary Embolism
1992 Standout
A Prospective Study of Venous Thromboembolism after Major Trauma
1994 Standout
Low Molecular Weight Heparin and Unfractionated Heparin in Thrombosis Prophylaxis: Meta-Analysis Based on Original Patient Data
2001
Antithrombotic Therapy for Venous Thromboembolic Disease
1989
Randomised controlled trial of steroid withdrawal in renal transplant recipients receiving triple immunosuppression
1996 StandoutNobel
Migraine — Current Understanding and Treatment
2002 Standout
Prevention of Venous Thromboembolism
2004 Standout
Thrombolysis with Alteplase 3 to 4.5 Hours after Acute Ischemic Stroke
2008 Standout
The Hazards of Scoring the Quality of Clinical Trials for Meta-analysis
1999 Standout
Treatment interventions for Parkinson's disease: an evidence based assessment
2002
Low-Molecular-Weight Heparin versus a Coumarin for the Prevention of Recurrent Venous Thromboembolism in Patients with Cancer
2003 Standout
Rivaroxaban versus Enoxaparin for Thromboprophylaxis after Hip Arthroplasty
2008 Standout
A comparative trial of a low molecular weight heparin (enoxaparin) versus standard heparin for the prophylaxis of postoperative deep vein thrombosis in general surgery
1995
Prevention of Venous Thromboembolism
2008 Standout
Balance of Symptomatic Pulmonary Embolism and Symptomatic Intracerebral Hemorrhage with Low-dose Anticoagulation in Recent Ischemic Stroke: A Systematic Review and Meta-analysis of Randomized Controlled Trials
2012
A Comparison of Low-Molecular-Weight Heparin with Unfractionated Heparin for Unstable Coronary Artery Disease
1997 Standout
The Pathogenesis of Coronary Artery Disease and the Acute Coronary Syndromes
1992 Standout
Antithrombotic Therapy for Venous Thromboembolic Disease
2001 Standout
Prevention of thromboembolism in 190 hip arthroplasties: Comparison of LMW heparin andplacebo
1991
Low-molecular-weight heparin versus standard heparin in general and orthopaedic surgery: a meta-analysis
1992
A Comparison of Enoxaparin with Placebo for the Prevention of Venous Thromboembolism in Acutely Ill Medical Patients
1999 Standout
Guidelines of care for the management of psoriasis and psoriatic arthritis
2009
Antithrombotic and Hypofibrinogenetic Therapy in Acute Ischemic Stroke: What Is the Next Step?
2003
Prophylaxis of thromboembolism in general surgery: Comparison between standard heparin and fragmin
1990
Using Numerical Results from Systematic Reviews in Clinical Practice
1997
Pharmacotherapeutic Aspects of Unfractionated and Low Molecular Weight Heparins
1990
Hemorrhagic Complications of Anticoagulant Treatment
2004
Comparison of Antithrombin Activity of the Polysulphate Chitosan Derivatives in In Vivo and In Vitro System
2001
The Cochrane Collaboration's tool for assessing risk of bias in randomised trials
2011 Standout
Guidelines for the Early Management of Adults With Ischemic Stroke
2007 Standout
Low molecular weight heparin in prevention of perioperative thrombosis.
1992
Heparins and mechanical methods for thromboprophylaxis in colorectal surgery
2003
Levodopa-Induced Neurotoxicity
1997
Guidelines for the Early Management of Patients With Acute Ischemic Stroke
2013 Standout
Attempts to obtain neuroprotection in Parkinson's disease
1997
THROMBOPROPHYLAXIS AND DEATH AFTER TOTAL HIP REPLACEMENT
1996
Low molecular weight heparin for the prevention of venous thromboembolism after abdominal surgery
2004
AHA/ACC Guidelines for Secondary Prevention for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2006 Update
2006 Standout
Are There Patients With Acute Ischemic Stroke and Atrial Fibrillation That Benefit From Low Molecular Weight Heparin?
2006
Low-Molecular-Weight Heparins Compared with Unfractionated Heparin for Treatment of Acute Deep Venous Thrombosis
1999
Low Molecular Weight Heparin
1997
Early combination therapy with bromocriptine and levodopa in parkinson's disease
1993
Efficacy and Safety of Anticoagulant Treatment in Acute Cardioembolic Stroke
2007
Socioeconomic Inequalities in Cardiovascular Disease in an Ageing Population
1999
Anticoagulants and antiplatelet agents in acute ischemic stroke [RETIRED]
2002
Prevention of Venous Thromboembolism
1992
Considering the Role of Heparin and Low-Molecular-Weight Heparins in Acute Ischemic Stroke
2002
Perioperative low-molecular-weight heparin. Is it effective and safe
1995
Blood pressure reduction in elderly: a randomised controlled trial of methyldopa.
1981
Glucocorticoid Therapy for Immune-Mediated Diseases: Basic and Clinical Correlates
1993
Prophylaxis of Thrombotic and Embolic Events in Acute Ischemic Stroke With the Low-Molecular-Weight Heparin Certoparin
2005
Use of Intravenous Heparin by North American Neurologists
2002
Prophylaxis of postoperative thromboembolism with low molecular weight heparins
1993
European Stroke Initiative Recommendations for Stroke Management – Update 2003
2003
Anticoagulants and Antiplatelet Agents in Acute Ischemic Stroke
2002
A randomised controlled study comparing bromocriptine to which levodopa was later added, with levodopa alone in previously untreated patients with Parkinson's disease: a five year follow up.
1994
Comparison of a low molecular weight heparin and unfractionated heparin for the prevention of deep vein thrombosis in patients undergoing abdominal surgery
1988
A Meta-analysis of Methods to Prevent Venous Thromboembolism Following Total Hip Replacement
1994
Low Molecular Weight Heparin and Prevention of Postoperative Thrombosis in Abdominal Surgery
1992
Blood pressure, stroke, and coronary heart disease
1990 Standout
Main properties and current applications of some polysaccharides as biomaterials
2007 Standout
Guidelines for the Early Management of Patients With Ischemic Stroke
2003
Thromboprophylaxis and early antithrombotic therapy in patients with acute ischemic stroke and cerebral venous and sinus thrombosis.
2004
Emergent Use of Anticoagulation for Treatment of Patients With Ischemic Stroke
2002
Low-Molecular-Weight Heparins
1997 Standout
Protection from Oxidative Stress–Induced Apoptosis in Cortical Neuronal Cultures by Iron Chelators Is Associated with Enhanced DNA Binding of Hypoxia-Inducible Factor-1 and ATF-1/CREB and Increased Expression of Glycolytic Enzymes, p21waf1/cip1, and Erythropoietin
1999 StandoutNobel
Prophylaxis of postoperative venous thrombosis in a controlled trial comparing dextran 70 and low‐dose heparin
1980
Low molecular weight heparin and unfractionated heparin in thrombosis prophylaxis after major surgical intervention: Update of previous meta-analyses
1997
Should treatment of Parkinson's disease be started with a dopamine agonist?
1998
Increased thrombin levels during thrombolytic therapy in acute myocardial infarction. Relevance for the success of therapy.
1991
CAR T cell immunotherapy for human cancer
2018 StandoutScience
Bone metabolism and disease in chronic kidney disease
2003
Chitosan Chemistry and Pharmaceutical Perspectives
2004 Standout
Pathophysiology, Clinical Presentation, and Treatment of Psoriasis
2020 Standout
Meta-analysis of low molecular weight heparin in the prevention of venous thromboembolism in general surgery
2001
Intravenous Heparin Started Within the First 3 Hours After Onset of Symptoms as a Treatment for Acute Nonlacunar Hemispheric Cerebral Infarctions
2005
Works of D. Welzel being referenced
[Quantitative assessment of drug-induced prophylaxis of postoperative thromboembolism. Comparison of frequencies of deep vein thrombosis and pulmonary embolism using acetylsalicylic-acid, dextran, dihydroergotamine, low-dose heparin and the fixed combination of heparin and dihydroergotamine (author's transl)].
1977
Cyclosporine in psoriasis: A multicenter dose-finding study in severe plaque psoriasis
1992
Comparison of the Efficacy and Safety of Sandoz Low Molecular Weight Heparin and Unfractionated Heparin: Interim Analysis of a Multicenter Trial
1991
Fixed combinations of low-molecular weight or unfractionated heparin plus dihydroergotamine in the prevention of postoperative deep vein thrombosis
1989
Anticoagulant and antithrombotic actions of a semisynthetic β-1,3-glucan sulfate
1995
Early institution of bromocriptine in Parkinson's disease inhibits the emergence of levodopa-associated motor side effects. Long-term results of the PRADO study
1996
Short-duration treatment of fingernail dermatophytosis: A randomized, double-blind study with terbinafine and griseofulvin
1995
Long-term maintenance therapy with cyclosporine and posttreatment survey in severe psoriasis: Results of a multicenter study
1995
Salmon calcitonin in the therapy of corticoid-induced osteoporosis
1987
Low dose urokinase preactivated natural prourokinase for thrombolysis in acute myocardial infarction
1989
Bromocriptine lessens the incidence of mortality in L-Dopa-treated parkinsonian patients: Prado-study discontinued
1992
[Evaluation of the prevention of perioperative thromboembolism with low molecular weight heparin and dihydroergotamine. A study of the incidence of lethal pulmonary embolisms and undesired symptoms, especially the risk of vasospasm and myocardial infarction].
1988
Thromboembolic prophylaxis in hip fracture
1986
Treatment of Acute Ischemic Stroke With the Low-Molecular-Weight Heparin Certoparin
2001
Prophylaxis of deep vein thrombosis in high risk patients undergoing total hip replacement with low molecular weight heparin plus dihydroergotamine.
1987
Antithrombotic defense during the postoperative period. Clinical documentation of low molecular weight heparin.
1988
Antihypertensive Treatment in the Elderly
1982
Low molecular weight heparin plus dihydroergotamine for prophylaxis of postoperative deep vein thrombosis
1986
Kombinationsbehandlung früher Stadien des Parkinson-Syndroms mit Bromocriptin und Levodopa: Ergebnisse einer multizentrischen Studie
2008
[Beta receptor block versus calcium antagonism. A comparative study of bopindolol and nifedipine with special regard to quality of life].
1989